Editorial for “Added Value of [<scp>18F</scp>]<scp>PSMA</scp>‐1007 <scp>PET</scp>/<scp>CT</scp> and <scp>PET</scp>/<scp>MRI</scp> in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management”-Reference-Cited by-同舟云学术

Editorial for “Added Value of [18F]PSMA‐1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management”

Published:2024-05-07 Issue: Volume: Page:
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:Magnetic Resonance Imaging

Author:

Moses Daniel Aaron¹^ORCID,Ho Shon Ivan²^ORCID

Affiliation:

1. Department of Medical Imaging Prince of Wales Hospital, Graduate School of Biomedical Engineering, University of New South Wales Sydney New South Wales Australia

2. Department of Nuclear Medicine and PET Prince of Wales Hospital, Discipline of Medicine, UNSW Medicine & Health, University of New South Wales Sydney New South Wales Australia

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.29426

Reference10 articles.

1. EAU‐EANM‐ESTRO‐ESUR‐SIOG guidelines on prostate cancer. Part II‐2020 update: Treatment of relapsing and metastatic prostate cancer;Cornford P;Eur Urol,2021

2. EAU‐EANM‐ESTRO‐ESUR‐SIOG guidelines on prostate cancer‐2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent;Mottet N;Eur Urol,2021

3. Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: A systematic review and meta‐analysis;Ma W;Eur Radiol,2022

4. Recurrent prostate cancer: Combined role for MRI and PSMA‐PET in (68)Ga‐PSMA‐11 PET/MRI;Jannusch K;Eur Radiol,2023

5. Histopathologically validated diagnostic accuracy of PSMA‐PET/CT in the primary and secondary staging of prostate cancer and the impact of PSMA‐PET/CT on clinical management: A systematic review and meta‐analysis;Jeet V;Semin Nucl Med,2023